REMEDY : BNSSG referral pathways & Joint Formulary

Home > Formulary : Paediatric > Paediatric Chapters > 14. Immunological products and vaccines >

BNSSG Paediatric Joint Formulary

14.4 Vaccines

Last edited: 31-01-2024

First line drugs Second line drugs Specialist drugs Secondary care drugs

14.4 Vaccines

For specific enquiries please contact:

  • Primary Care:
    • Public health England on 03003038162
  • Secondary Care:
    • NBT - Medicines Information: 0117 4142282
    • UHB - Medicines Information: 0117 3420000


Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B (Infanrix hexa®) (TLS Green)

Diphtheria, tetanus, pertussis and polio (Repevax® or Boostrix-IPV®) (TLS green)

BCG vaccine (TLS Green)

Haemophilus influenzae type B and Neisseria meningitides group C vaccine (Menitorix®) (TLS Green)

Hepatitis A vaccine (TLS Green)

Hepatitis B vaccine (TLS Green)

Hepatitis B vaccine (HBvaxPRO® 40microgram, Engerix B®) (TLS Amber Specialist Recommended)

  • Engerix B® is a suitable alternative but please note there are different dosing schedules - see SCP above

Hepatitis A with Hepatitis B vaccine (Twinrix®) (TLS Green)

Human papilloma vaccine (Gardasil®) (TLS Green)

Influenza vaccine (TLS Green)

Measles, Mumps and Rubella (MMR Vax PRO® or Priorix®) vaccine (TLS Green)

Meningococcal Group C conjugate vaccine (TLS Green)

Meningococcal Group B vaccine (Bexsero®) (TLS Green)

Meningococcal Groups A, C, W135 and Y Conjugate vaccine (Menveo® or Nimenrix®) (TLS Green)

  • As per immunisation schedule

Pneumococcal polysaccharide vaccine (TLS Green)

Pneumococcal vaccine (Prevenar 13®) (TLS Green)

  • In accordance with Department of Health/Public Health England guidance

Rabies vaccine (Rabipur®) (TLS Green)

Rotavirus (Rotarix®) (TLS Green)

Tetanus, Diphtheria and Polio (Revaxis®) (TLS Green)

Typhoid vaccine (TLS Green)

Varicella-zoster vaccine (Zostavax®) (TLS Green)

Varicella-zoster vaccine (Varilrix® or Varivax®) (TLS Green)

COVID vaccine (TLS Green)

  • Where supported by JVCI guidance


Respiratory Syncytial Virus

Palivizumab (TLS Red)

  • According to NHS England criteria